semaglutide for non obese Semaglutide: Transform Your Health & Weight Loss GLP-1 medications are changing the

Tirzepatide-Specific Safety Considerations GI symptoms are generally mild to moderate Risk of hypoglycemia when used with insulin or sulfonylureas Rare risk of pancreatitis (class effect) Possible thyroid C-cell effects (class warning) Heart rate increases have been documented, but are generally modest Retatrutide-Specific Safety Considerations Higher overall rate of side effects compared to tirzepatide in Phase 2 data More pronounced heart rate increase this is a dose-dependent effect directly related to glucagon receptor activation (glucagon is known to increase heart rate in pharmacological doses) At 12 mg doses, some participants experienced increases in heart rate of 46 bpm above baseline

Eating too little can create an unpredictable metabolism because your body cannot establish a consistent energy baseline

Longer-term data on sustained efficacy, relapse rates after discontinuation, and psychological outcomes are still needed

Improved Metabolic Health: By regulating both appetite and blood sugar, GLP-1 receptor agonists not only assist in weight loss but also help reduce the risk of diabetes-related complications